Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 19 Similar Profiles
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinoma, squamous cell of head and neck Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Oropharyngeal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2017

Differences in the prevalence of human papillomavirus (HPV) in head and neck squamous cell cancers by sex, race, anatomic tumor site, and HPV detection method

D'Souza, G., Westra, W. H., Wang, S. J., Van Zante, A., Wentz, A., Kluz, N., Rettig, E., Ryan, W. R., Ha, P. K., Kang, H., Bishop, J., Quon, H., Kiess, A. P., Richmon, J. D., Eisele, D. W. & Fakhry, C. Feb 1 2017 In : JAMA Oncology. 3, 2, p. 169-177 9 p.

Research output: Research - peer-reviewArticle

Squamous Cell Neoplasms
Head and Neck Neoplasms
In Situ Hybridization
Head
Neoplasms

Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma

Malm, I. J., Fan, C. J., Yin, L. X., Li, D. X., Koch, W. M., Gourin, C. G., Pitman, K. T., Richmon, J. D., Westra, W. H., Kang, H., Quon, H., Eisele, D. W. & Fakhry, C. 2017 (Accepted/In press) In : Cancer.

Research output: Research - peer-reviewArticle

Oropharyngeal Neoplasms
Squamous Cell Carcinoma
Neoplasm Staging
Survival
Disease-Free Survival

Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer

Anagnostou, V. , Smith, K. N. , Forde, P. M. , Niknafs, N. , Bhattacharya, R. , White, J. , Zhang, T. , Adleff, V. , Phallen, J. , Wali, N. , Hruban, C. , Guthrie, V. B. , Rodgers, K. , Naidoo, J. , Kang, H. , Sharfman, W. , Georgiades, C. , Verde, F. , Illei, P. , Li, Q. K. & 9 others Gabrielson, E., Brock, M. V., Zahnow, C. A., Baylin, S. B., Scharpf, R. B., Brahmer, J. R., Karchin, R., Pardoll, D. M. & Velculescu, V. E. Mar 1 2017 In : Cancer Discovery. 7, 3, p. 264-276 13 p.

Research output: Research - peer-reviewArticle

Non-Small Cell Lung Carcinoma
Neoplasms
T-Lymphocytes
Mutation
Therapeutics

Pembrolizumab for platinum- and cetuximab-refractory head and neck cancer: Results from a single-arm, phase II study

Bauml, J., Seiwert, T. Y., Pfister, D. G., Worden, F., Liu, S. V., Gilbert, J., Saba, N. F., Weiss, J., Wirth, L., Sukari, A., Kang, H., Gibson, M. K., Massarelli, E., Powell, S., Meister, A., Shu, X., Cheng, J. D. & Haddad, R. May 10 2017 In : Journal of Clinical Oncology. 35, 14, p. 1542-1549 8 p.

Research output: Research - peer-reviewArticle

Head and Neck Neoplasms
Platinum
Therapeutics
Cetuximab
pembrolizumab
Laryngeal Neoplasms
Costs and Cost Analysis
Therapeutics
Odds Ratio
Quality of Health Care